The DOI matches its Crossref record; 78 of the 84 references it cites were found in a registry or an index.
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.
Open accessAbstract
Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein. Because no known kinase has been identified that can modify this site, HeLa nuclear extracts were fractionated and S20 phosphorylation was followed. We discovered that a S20 kinase activity copurifies with the human homolog of the Schizosaccharomyces pombe checkpoint kinase, Chk1 (hCHK1). We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase. It is interesting that hCHK1 strongly prefers tetrameric to monomeric p53 in vitro, consistent with our observation that phosphorylation of amino-terminal sites in vivo requires that p53 be oligomeric. Regulation of the levels and activity of hCHK1 in transfected cells is directly correlated with the levels of p53; expression of either a kinase-defective hCHK1 or antisense hCHK1 leads to reduced levels of cotransfected p53, whereas overexpression of wild-type hCHK1 or the kinase domain of hCHK1 results in increased levels of expressed p53 protein. The human homolog of the second S. pombe checkpoint kinase, Cds1 (CHK2/hCds1), phosphorylates tetrameric p53 but not monomeric p53 in vitro at sites similar to those phosphorylated by hCHK1 kinase, suggesting that both checkpoint kinases can play roles in regulating p53 after DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and hChk2, in turn, phosphorylates yet another amino-terminal Ser residue (Ser 20) in p53”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Shieh et al. 2000
In the citing paper
“These phosphorylation events contribute to disrupting the p53-Mdm2 (Chehab et al., 2000; Shieh et al., 2000), and Mdm2-DAXX (Tang et al., 2013) interactions, as well as to the degradation of Mdm2 and Mdm4 (Stommel and Wahl, 2004; Chen et al., 2005; Pereg et al., 2005, 2006; LeBron et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Shieh et al., 2000
In the citing paper
“p53 is phosphorylated at Ser20 by the checkpoint kinase Chk2 after IR, which results in p53's dissociation from Mdm2 and its subsequent stabilization”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Shieh et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Another p53 target gene, MDM2, encodes a p53-binding protein that negatively regulates the activity (Momand et al. 1992; Oliner et al. 1993) and the stability of p53 (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citationCell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Self-citationEnhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citationOncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474
Flagged first, then by citations
6 of the 84 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mayo, 1997, Mdm2 phosphorylation by DNA-dependent protein kinase prevents ineraction with p53., Cancer Res., 57, 5013
Cited by
Sorted by citations
Items 201–300 of 964
Replication fork dynamics and the DNA damage response
Jones, R. M., & Petermann, E. (2012) · Biochemical Journal · doi:10.1042/bj20112100 · Cited by 140
p53 tetramerization: at the center of the dominant-negative effect of mutant p53Preprint
Gencel‐Augusto, J., & Lozano, G. (2020) · Genes & Development · doi:10.1101/gad.340976.120 · Cited by 136
Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600363 · Cited by 124
Biological determinants of radioresistance and their remediation in pancreatic cancer
Seshacharyulu, P., Baine, M. J., Souchek, J. J., Menning, M., Kaur, S., Yan, Y., Ouellette, M. M., Jain, M., Lin, C. H., & Batra, S. K. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.003 · Cited by 127
Kishi, H., Nakagawa, K., Matsumoto, M., Suga, M., Ando, M., Taya, Y., & Yamaizumi, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105134200 · Cited by 129
Self-citationApoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2
Rogoff, H. A., Pickering, M., Frame, F. M., Debatis, M. E., Sánchez, Y., Jones, S. N., & Kowalik, T. F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2968-2977.2004 · Cited by 123
DNA damage and cell cycle checkpoints in hyperoxic lung injury: braking to facilitate repair
O’Reilly, M. A. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.2.l291 · Cited by 122
Curman, D., Cinel, B., Williams, D. E., Rundle, N. T., Block, W. D., Goodarzi, A. A., Hutchins, J. R. A., Clarke, P. R., Zhou, B.-B., Lees‐Miller, S. P., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100728200 · Cited by 121
Intracellular signal transduction of cells in response to carcinogenic metals
Chen, F., & Shi, X. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00211-6 · Cited by 121
Regulation of cellular senescence via the FOXO 4‐p53 axis
Bourgeois, B. M. R., & Madl, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13057 · Cited by 124
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F‐1 after DNA damage
Inoue, Y., Kitagawa, M., & Taya, Y. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601652 · Cited by 119
Self-citationThe multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen, Y., & Poon, R. Y. C. (2008) · PubMed · doi:10.2741/3060 · Cited by 119
Chen, M.-J., Lin, Y.-T., Lieberman, H. B., Chen, G., & Lee, E. Y.-H. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008871200 · Cited by 119
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Li, H.-H., Li, A. G., Sheppard, H. M., & Liu, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00123-6 · Cited by 118
Recognition and Management of Hereditary Breast Cancer Syndromes
Thull, D. L., & Vogel, V. G. (2004) · The Oncologist · doi:10.1634/theoncologist.9-1-13 · Cited by 118
Activation of p53 by roscovitine-mediated suppression of MDM2 expression
Lu, W., Chen, L., Peng, Y., & Chen, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204412 · Cited by 117
Tumor Suppressor CHK2: Regulator of DNA Damage Response and Mediator of Chromosomal Stability
Stolz, A., Ertych, N., & Bastians, H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1215 · Cited by 120
DNA-dependent Acetylation of p53 by the Transcription Coactivator p300
Dornan, D., Shimizu, H., Perkins, N. D., & Hupp, T. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211460200 · Cited by 120
BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells
Ranuncolo, S. M., Polo, J. M., & Melnick, A. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.02.003 · Cited by 116
Shimizu, H., Burch, L. R., Smith, A. J., Dornan, D., Wallace, M., Ball, K. L., & Hupp, T. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202296200 · Cited by 116
p53: Twenty five years understanding the mechanism of genome protection
Gómez-Lázaro, M., Fernández-Gómez, F.-J., & Jordán, J. (2004) · Journal of Physiology and Biochemistry · doi:10.1007/bf03167075 · Cited by 119
Moreno, N. N., Olthof, A. M., & Svejstrup, J. Q. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052621-091205 · Cited by 119
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114
“These phosphorylation events contribute to disrupting the p53-Mdm2 (Chehab et al., 2000; Shieh et al., 2000), and Mdm2-DAXX (Tang et al.”
BackgroundFalck, J., Lukas, C., Protopopova, M., Lukas, J., Selivanova, G., & Bártek, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204811 · Cited by 114
Piecing Together the p53 Puzzle
Carr, A. M. (2000) · Science · doi:10.1126/science.287.5459.1765 · Cited by 113
14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
Jin, Y., Dai, M., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., & Lu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601010 · Cited by 116
Distinct mechanisms act in concert to mediate cell cycle arrest
Toettcher, J. E., Loewer, A., Ostheimer, G. J., Yaffe, M. B., Tidor, B., & Lahav, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806196106 · Cited by 112
Sakai, D., Dixon, J., Achilleos, A., Dixon, M. J., & Trainor, P. A. (2016) · Nature Communications · doi:10.1038/ncomms10328 · Cited by 117
Regulation of p53 Stability and Function in HCT116 Colon Cancer Cells
Kaeser, M. D., Kaeser-Pebernard, S., & Iggo, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311732200 · Cited by 113
Prevalence of Early Onset Colorectal Cancer in 397 Patients With Classic Li–Fraumeni Syndrome
Wong, P., Verselis, S. J., Garber, J. E., Schneider, K. A., DiGianni, L. M., Stockwell, D. H., Li, F. P., & Syngal, S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.014 · Cited by 111
E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis
Rogoff, H. A., Pickering, M., Debatis, M. E., Jones, S. N., & Kowalik, T. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5308-5318.2002 · Cited by 111
Dornan, D., Shimizu, H., Burch, L. R., Smith, A. J., & Hupp, T. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8846-8861.2003 · Cited by 108
Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death
Lee, J.-H., Kim, H.-S., Lee, S., & Kim, K. (2007) · Journal of Cell Science · doi:10.1242/jcs.03468 · Cited by 110
Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor
McGowan, C. H. (2002) · BioEssays · doi:10.1002/bies.10101 · Cited by 109
Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks
Buscemi, G., Perego, P., Carenini, N., Nakanishi, M., Chessa, L., Chen, J., Khanna, K. K., & Delia, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207986 · Cited by 110
Hershko, T., Chaussepied, M., Oren, M., & Ginsberg, D. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401575 · Cited by 107
Regulation of p53 - insights into a complex process
Boehme, K. A., & Blattner, C. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903401507 · Cited by 107
Liu, G., & Chen, X. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1398-1413.2006 · Cited by 104
Mutation of Mouse p53 Ser23 and the Response to DNA Damage
Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103
Neganova, I. E., Tilgner, K., Buskin, A., Paraskevopoulou, I., Atkinson, S. P., Peberdy, D., Passos, J. F., & Lako, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.464 · Cited by 103
Yıldız, A., Kaya, Y., & Tanrıverdi, Ö. (2019) · Journal of Cancer Prevention · doi:10.15430/jcp.2019.24.3.146 · Cited by 103
Park, Y.-H., Kim, D., Dai, J., & Zhang, Z. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.008 · Cited by 104
Sumoylation of Mdm2 by Protein Inhibitor of Activated STAT (PIAS) and RanBP2 Enzymes
Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., & Yasuda, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208319200 · Cited by 102
Chemistry and Biology of Acylfulvenes: Sesquiterpene-Derived Antitumor Agents
Tanasova, M., & Sturla, S. J. (2012) · Chemical Reviews · doi:10.1021/cr2001367 · Cited by 101
The Role of p53 Gene Family in ReproductionPreprint
Hu, W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001073 · Cited by 104
Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
Ahn, J., Urist, M., & Prives, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213185200 · Cited by 99
Self-citationRegulation of the p53 transcriptional activity
Liu, G., & Chen, X. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 100
ATR Is Not Required for p53 Activation but Synergizes with p53 in the Replication Checkpoint
Nghiem, P., Park, P. K., Kim, Y.-S., Desai, B. N., & Schreiber, S. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106113200 · Cited by 99
Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.
Satyamoorthy, K., Chehab, N. H., Waterman, M. J. F., Lien, M. C., El‐Deiry, W. S., Herlyn, M., & Halazonetis, T. D. (2000) · PubMed · Cited by 98
Haoudi, A., Daniels, R. C., Wong, E. B., Kupfer, G. M., & Semmes, O. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301649200 · Cited by 98
Wei, J., Chou, Y., Ou, Y.-H., Yeh, Y.-H., Tyan, S., Sun, T.-P., Shen, C., & Shieh, S.-Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410152200 · Cited by 99
Self-citationNegative Cell Cycle Regulation and DNA Damage-inducible Phosphorylation of the BRCT Protein 53BP1
Xia, Z., Morales, J. C., Dunphy, W. G., & Carpenter, P. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007665200 · Cited by 96
Vogt Sionov, R., Coen, S., Goldberg, Z., Berger, M., Bercovich, B., Ben-Neriah, Y., Ciechanover, A., & Haupt, Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5869-5878.2001 · Cited by 94
Blanco, S., Klimčáková, L., Vega, F. M. D. L., & Lazo, P. A. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05256.x · Cited by 95
Mammalian TIMELESS Is Required for ATM-dependent CHK2 Activation and G2/M Checkpoint Control
Yang, X., Wood, P. A., & Hrushesky, W. J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050237 · Cited by 98
Li, D. W.-C., Liu, J.-P., Schmid, P. C., Schlosser, R., Feng, H., Liu, W.-B., Yan, Q., Gong, L., Sun, S.-M., Deng, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209334 · Cited by 98
Genetic insights into familial cancers – update and recent discoveries
Marsh, D. J., & Zori, R. T. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00023-x · Cited by 94
Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export
Shinozaki, T., Nota, A., Taya, Y., & Okamoto, K. (2003) · Oncogene · doi:10.1038/sj.onc.1207176 · Cited by 93
Self-citationPetsalaki, E., & Zachos, G. (2020) · FEBS Journal · doi:10.1111/febs.15240 · Cited by 98
Hypoxia attenuates the p53 response to cellular damage
Achison, M., & Hupp, T. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206434 · Cited by 93
ATM/ATR checkpoint activation downregulates CDC25C to prevent mitotic entry with uncapped telomeres
Thanasoula, M., Escandell, J. M., Suwaki, N., & Tarsounas, M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.191 · Cited by 99
Phosphatases in the cellular response to DNA damage
Freeman, A. K., & Monteiro, Á. N. A. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-27 · Cited by 104
Agarwal, S., Bell, C. M., Rothbart, S. B., & Moran, R. G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665133 · Cited by 97
Calpains Mediate p53 Activation and Neuronal Death Evoked by DNA Damage
Sedarous, M., Keramaris, E., O'Hare, M., Melloni, E., Slack, R. S., Elce, J. S., Greer, P. A., & Park, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302833200 · Cited by 94
Chk2 regulates irradiation-induced, p53-mediated apoptosis in Drosophila
Peters, M., DeLuca, C., Hirao, A., Stambolic, V., Potter, J., Zhou, L., Silvester, J., Snow, B. E., Arya, S., Wong, J. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172382899 · Cited by 93
hADA3 is required for p53 activity
Wang, T., Kobayashi, T., Takimoto, R., Denes, A. E., Snyder, E. L., El‐Deiry, W. S., & Brachmann, R. K. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6404 · Cited by 93
Tse, A. N., & Schwartz, G. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0841 · Cited by 94
Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300
Dornan, D., & Hupp, T. R. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve025 · Cited by 93
Nucleolar Proteins Suppress Caenorhabditis elegans Innate Immunity by Inhibiting p53/CEP-1
Fuhrman, L. E., Goel, A., Smith, J. P., Shianna, K. V., & Aballay, A. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000657 · Cited by 92
Zhang, H., Xu, J., Long, Y., Maimaitijiang, A., Su, Z., Li, W., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312928 · Cited by 97
Chen, H., Zhang, S., Gao, X., Gao, X., Xu, X., LV, Y. J., Zhang, Y., Zhu, Z., Zhang, C., Li, Q., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313262 · Cited by 98
Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation
Damia, G. L. M., Filiberti, L., Vikhanskaya, F., Carrassa, L., Taya, Y., D’Incalci, M., & Broggini, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900122 · Cited by 96
Self-citationÅnensen, N., Oyan, A. M., Bourdon, J., Kalland, K. H., Bruserud, Ø., & Gjertsen, B. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1970 · Cited by 94
Rao, P. S., Satelli, A., Moridani, M. Y., Jenkins, M., & Rao, U. S. (2011) · International Journal of Cancer · doi:10.1002/ijc.26308 · Cited by 90
Stoichiometric Phosphorylation of Human p53 at Ser315Stimulates p53-dependent Transcription
Blaydes, J. P., Luciani, M. G., Pospı́šilová, Š., Ball, H. M.-L., Vojtesek, B., & Hupp, T. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003485200 · Cited by 91
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 95
Self-citationRadiation and the cell cycle, revisited
Wilson, G. D. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031762.91306.b4 · Cited by 91
Zgheib, O., Huyen, Y., DiTullio, R. A., Snyder, A. R., Venere, M., Stavridi, E. S., & Halazonetis, T. D. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.026 · Cited by 90
Platinum Complexes in Colorectal Cancer and Other Solid Tumors
Köberle, B., & Schoch, S. (2021) · Cancers · doi:10.3390/cancers13092073 · Cited by 88
Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation
Mistriotis, P., & Andreadis, S. T. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.05.006 · Cited by 89
Drosophila Chk2 is required for DNA damage‐mediated cell cycle arrest and apoptosis
Xu, J., Xin, S., & Du, W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03103-9 · Cited by 87
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
Bell, D. W., Kim, S. H., Godwin, A. K., Schiripo, T. A., Harris, P. L., Haserlat, S. M., Wahrer, D. C. R., Haiman, C. A., Daly, M. B., Niendorf, K. B., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23026 · Cited by 90
Wichmann, A., Jaklevic, B. R., & Su, T. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510528103 · Cited by 89
Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress
Klibanov, S. A., O’Hagan, H. M., & Ljungman, M. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1867 · Cited by 88
Lezina, L., Purmessur, N. S., Antonov, A. V., Ivanova, T., Karpova, E., Kumar, K., Ivan, M., Aksenova, V., Tentler, D., Garabadgiu, A. V., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.483 · Cited by 90
Inoue, N., Yahagi, N., Yamamoto, T., Ishikawa, M., Watanabe, K., Matsuzaka, T., Nakagawa, Y., Takeuchi, Y., Kobayashi, K., Takahashi, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801824200 · Cited by 86
MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation
Jin, Y., Zeng, S. X., Dai, M., Yang, X., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204078200 · Cited by 86
Yeh, P.-Y., Chuang, S., Yeh, K., Song, Y., Chang, L. L.-Y., & Cheng, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207426 · Cited by 89
Liu, J., Zhu, Y., Chen, I., Lau, J., He, F., Lau, A., Wang, Z., Karuppannan, A. K., & Kwang, J. (2007) · Journal of Virology · doi:10.1128/jvi.00681-07 · Cited by 86
Skalska, L., White, R. E., Parker, G. A., Sinclair, A. J., Paschos, K., & Allday, M. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003187 · Cited by 87
Hypoxia-Induced Phosphorylation of Chk2 in an Ataxia Telangiectasia Mutated–Dependent Manner
Gibson, S. L., Bindra, R. S., & Glazer, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1160 · Cited by 85
Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein
Kimura, S. H., & Nojima, H. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00564.x · Cited by 85
p53 Activation by Nitric Oxide Involves Down-regulation of Mdm2
Wang, X., Michael, D., de MURCIA, G., & Oren, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112068200 · Cited by 84
The role of SOG1, a plant-specific transcriptional regulator, in the DNA damage response
Yoshiyama, K., Kimura, S., Maki, H., Britt, A., & Umeda, M. (2014) · Plant Signaling & Behavior · doi:10.4161/psb.28889 · Cited by 86
Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells
Gogineni, V. R., Nalla, A. K., Gupta, R., Dinh, D. H., Klopfenstein, J. D., & Rao, J. S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.08.022 · Cited by 83
Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions
Gopal, Y. N. V., Chanchorn, E., & Dyke, M. W. V. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0661 · Cited by 83
Regulation of MDMX Expression by Mitogenic Signaling
Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., & Chen, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01633-07 · Cited by 82
Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Jovanović, K., Escure, G., Demonchy, J., Willaume, A., de Wyngaert, Z. V., Farhat, M.-M., Chauvet, P., Facon, T. T. F., Quesnel, B., & Manier, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2018.00665 · Cited by 86
Alternative splicing and mutation status of CHEK2 in stage III breast cancer
Staalesen, V., Falck, J., Geisler, S. B., Bártková, J., Børresen‐Dale, A., Lukas, J., Lillehaug, J. R., Bártek, J., & Lønning, P. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207928 · Cited by 88
Importance of DNA damage checkpoints in the pathogenesis of human cancers
Poehlmann, A., & Roessner, A. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.06.006 · Cited by 88
Metadata
- Authors
- Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C.
- Affiliations
- Seisen University (JP)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-02-01
- Volume
- 14
- Issue
- 3
- Pages
- 289-300
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316358
- OpenAlex
- W2120921507
- Cited by
- 972
- References
- 84
- Citations by year
- 2026: 11 · 2025: 4 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 24 · 2014: 39 · 2013: 38 · 2012: 42
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Princess Takamatsu Cancer Research Fund
- National Institutes of Health (CA58316)
- National Cancer Institute (R37CA058316, R01CA058316, CA 58316)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53 phosphorylation, Chk1, Chk2, checkpoint kinase, DNA damage response, p53 oligomerization, p53 stabilization, Schizosaccharomyces pombe, kinase activity
- MeSH terms
- Checkpoint Kinase 1, DNA Damage, HeLa Cells, Humans, Phosphorylation, Protein Kinases, Recombinant Proteins, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Schizosaccharomyces pombe Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review